about
Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedemaAngioedema without urticaria: a large clinical surveyC1 inhibitor deficiency: consensus documentClassification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupSelf-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptanceNovel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P.A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitorsDefective glycosylation of coagulation factor XII underlies hereditary angioedema type IIIIcatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.Immediate-type allergy to drugs and related compounds: evaluation and management.Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it.The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema.Hereditary angioedema: epidemiology, management, and role of icatibantACE-I Angioedema: Accurate Clinical Diagnosis May Prevent Epinephrine-Induced Harm.Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema.An encounter with enalapril-induced resistant, life-threatening angioedema at rural health center in Botswana.Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.Unilateral tongue angioedema caused by angiotensin-converting enzyme inhibitor.Pleiotropic effects of angiotensin receptor blockers: addressing comorbidities by optimizing hypertension therapy.Therapeutic approaches in hereditary angioedema.Icatibant in hereditary angioedema: news and challenges.New topics in bradykinin research.Current pharmacotherapy of bradykinin-mediated angioedema.Non-histaminergic angioedema: focus on bradykinin-mediated angioedema.Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.Tracking down contact activation - from coagulation in vitro to inflammation in vivo.Management of angioedema without urticaria in the emergency department.Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.Predictors of Airway Intervention in Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.Angioedema Phenotypes: Disease Expression and Classification."Nuts and Bolts" of Laboratory Evaluation of Angioedema.The Story of Angioedema: from Quincke to Bradykinin.Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema.The complement and contact activation systems: partnership in pathogenesis beyond angioedema.Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema.Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans.Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema.
P2860
Q23915359-C704489D-59E5-48AB-B359-AD976061B2F5Q24673934-D937DE10-81E3-46C4-AFFA-20206202C109Q24684165-237D93FE-C511-44D9-B35C-14F192A2502BQ27009012-739AE288-35A8-4210-8FCE-C208D5CC7E6AQ28079761-AF83F13E-DB46-4BE3-9D48-AD1815ACD03CQ33560367-D73D9340-5BD5-42EE-9DC4-B2E12571B158Q34021159-B877D5A6-DD9E-4AC3-957A-AD3681E58BC2Q34114542-BE2416A9-C98A-4E90-A899-9E9FBA1546B2Q35700453-913FF6A1-FB84-47ED-B0CE-7C6DBE7F37D7Q36326043-0EA75B6F-074C-46F6-A28F-4B7540663A78Q36373700-824A37FA-D20C-43AD-9260-85A4ED35012EQ36406780-A4E41B11-A610-414D-8A44-00B90DFDAD7FQ36565040-3E84DD1F-6C19-4973-A6D6-3C63234AF23CQ36568742-CA5078A9-6B22-4288-A0BD-B2A491166BC5Q36825274-57679C43-AE9D-42D2-A19A-588D33A3D434Q36983928-261A943F-2F0F-4CDD-938A-10BFDE2193B2Q37013257-DDD45F53-A23C-4B2A-A5CC-76F066BE3A5FQ37356488-333EDFA6-583E-43A2-9B97-2E0F46CD9E5CQ37377943-B6AA8909-C617-486A-8B4C-DF582C3800AAQ37763312-662AD43D-604C-4595-B746-CE561633F1E1Q37826797-4CD40A8B-4E1C-44E0-A2EE-9212AF8528F2Q37833531-4065406D-5A6B-4D61-99DB-BEEACA53D4ADQ37877255-1AC256E4-2CDD-43EA-A98C-19B7F83988A5Q37920922-850B823D-EC80-437D-8F16-1937A92EE1BCQ38088259-D17BCD9C-25E7-4C87-9D2C-B3B1989C9000Q38091702-EB917D1F-BC60-4674-904B-45735E35CCEBQ38134036-C351B437-89B6-47EB-9136-430D492E0C1CQ38205955-05776CA6-1009-4D8A-AAC8-F6225764BFBBQ38314955-33F3627C-13C8-4E9B-8557-AE30C36AEAF7Q38443205-0FC2BC72-9E25-43B1-BC55-9273A673EE03Q38530515-BFADE07D-9A3F-420B-9B27-CC3FF1DD683AQ38817627-DF8A63E6-BB22-43AA-BE1B-BE3813AB3E1CQ38824626-A6EF3834-0ADA-4119-BDF4-5E33DC0E8E76Q38855032-4484034D-FCEA-4773-B245-176B0C33219FQ38857834-6C60491A-A7DB-4A05-9617-52366CEC06D5Q38991081-7B85A516-441F-4937-BC01-686843D4D204Q39003567-1B6F7124-0115-469C-8C63-5365B4957AFFQ39213357-59DF95D7-DC72-4260-A392-A55BC1CA14E6Q42260518-C7F9095A-45DB-4781-8127-9E76963BCABFQ43075819-075F0976-D8FD-4C70-9056-E3D95AA0DD8E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Bradykinin and the pathophysiology of angioedema.
@ast
Bradykinin and the pathophysiology of angioedema.
@en
type
label
Bradykinin and the pathophysiology of angioedema.
@ast
Bradykinin and the pathophysiology of angioedema.
@en
prefLabel
Bradykinin and the pathophysiology of angioedema.
@ast
Bradykinin and the pathophysiology of angioedema.
@en
P1476
Bradykinin and the pathophysiology of angioedema.
@en
P2093
Angelo Agostoni
Jürg Nussberger
P304
P356
10.1016/S1567-5769(02)00162-5
P577
2003-03-01T00:00:00Z